• mRNA with Cap1 Structure: Next-Gen Cas9 Control with EZ Cap™

  2026-06-13

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) redefines genome editing with advanced mRNA engineering, focusing on controlled Cas9 expression and specificity. Discover in-depth analysis and practical insights not found in existing resources.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Osteo

  2026-06-12

  Bazedoxifene stands out as a third-generation selective estrogen receptor modulator, enabling precise dissection of bone mineral density enhancement and estrogen receptor signaling in postmenopausal osteoporosis models. This article provides actionable workflows, troubleshooting insights, and protocol refinements drawn from the latest literature and APExBIO’s trusted product specification.

• Neuromedin S (rat): Technical Protocol and Workflow Guidance

  2026-06-12

  Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled activation of neuromedin U receptor signaling in rat-based GPCR/G protein pathway research. It is optimized for reproducible assays investigating energy homeostasis regulation and stress response. This product is not intended for diagnostic, therapeutic, or non-rat model applications.

• Toremifene in Prostate Cancer Metastasis: Beyond ER Modulati

  2026-06-11

  Discover how Toremifene, a selective estrogen-receptor modulator, enables advanced investigation of metastatic signaling in prostate cancer research. This article uniquely explores the intersection of ER modulation and the TSPAN18-STIM1-Ca2+ axis, providing new insight for hormone-responsive cancer assays.

• EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Genome Editing Precision

  2026-06-11

  EZ Cap™ Cas9 mRNA (m1Ψ) leverages Cap1 structure and m1Ψ modification for high-fidelity, immune-silent CRISPR-Cas9 genome editing in mammalian systems. Explore advanced workflows, troubleshooting, and the latest precision innovations to maximize editing success and minimize off-target effects.

• Cyanine 5-dCTP: High-Fidelity Fluorescent DNA Labeling Reage

  2026-06-10

  Cyanine 5-dCTP (Cy5-dCTP) is a fluorescent nucleotide analog enabling highly specific, red-fluorescent DNA labeling in enzymatic synthesis and PCR. It is validated for ≥95% purity, robust performance in DNA probe synthesis, and compatibility with advanced enzymatic workflows. APExBIO’s Cy5-dCTP supports precise nucleic acid detection and imaging applications.

• Vernakalant Hydrochloride: Experimental Strategies for Rapid

  2026-06-10

  Vernakalant Hydrochloride (RSD1235) is revolutionizing atrial fibrillation research with its atrial-selective, multi-ion channel blockade and rapid conversion profile. This guide details hands-on workflows, key PK/PD insights, and troubleshooting strategies to maximize experimental rigor in both in vitro and in vivo models.

• SU 5402 Workflows: Enhancing Cell Cycle Arrest & Apoptosis A

  2026-06-09

  SU 5402 enables precise receptor tyrosine kinase inhibition for dissecting cell signaling, cell cycle arrest, and apoptosis in cancer and neuronal models. This guide details evidence-based workflows, troubleshooting strategies, and cross-domain applications, grounded in the latest research.

• Bispecific Antibody Advances for Orthopoxvirus Protection

  2026-06-09

  The reference study introduces and characterizes potent monoclonal and bispecific antibodies targeting MPXV proteins M1R and B6R, offering broad-spectrum, enhanced antiviral efficacy. These findings inform new strategies for antibody-based therapeutics against emerging orthopoxvirus outbreaks, with robust validation in both in vitro and in vivo models.

• Nintedanib (BIBF 1120): Precision Antiangiogenic Strategies

  2026-06-08

  This article explores the mechanistic rationale and translational potential of Nintedanib (BIBF 1120), a nanomolar-potency triple angiokinase inhibitor, in the context of ATRX-deficient tumor models. Integrating recent evidence on receptor tyrosine kinase inhibition, we provide actionable guidance for researchers seeking to optimize antiangiogenic and antifibrotic research using Nintedanib, with practical protocol parameters and a critical outlook on future directions.

• Enhancing mRNA Delivery: Deep Dive into EZ Cap Cy5 Firefly L

  2026-06-08

  Discover how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers advanced mRNA delivery and transfection studies with dual-mode imaging and immune evasion. This article explores unique mechanistic insights and practical assay strategies for maximizing translational efficiency.

• PLK1 Phosphorylation Regulates p31comet in Mitotic Checkpoin

  2026-06-07

  This study uncovers how Polo-like kinase 1 (PLK1) suppresses the activity of p31comet during mitosis by direct phosphorylation, preventing premature disassembly of mitotic checkpoint complexes (MCC). These findings clarify a key regulatory mechanism in chromosome segregation and offer a foundation for precision targeting of mitotic control in cancer research.

• Silk Fibroin–Ce6 Electrospun Films for Antibacterial PDT

  2026-06-06

  This study introduces an aligned silk fibroin nanofiber film conjugated with Chlorin e6 (Ce6), enabling photodynamic antibacterial therapy against Staphylococcus aureus. The engineered scaffold demonstrates rapid reactive oxygen species generation, effective infection control, and macrophage modulation, offering a promising route for antibiotic-resistant wound management.

• Nintedanib (BIBF 1120): Mechanistic Insights for Translation

  2026-06-05

  This article explores how Nintedanib (BIBF 1120) redefines antiangiogenic strategies in translational research, with a focus on mechanistic rationale, emerging evidence in ATRX-deficient gliomas, and actionable protocol guidance.

• Vincristine Sulfate in Cancer Research: Protocol Optimizatio

  2026-06-05

  Vincristine sulfate is a cornerstone in cancer research, prized for its precision in disrupting microtubule dynamics and potent activity against diverse tumor types. This article delivers hands-on protocol enhancements, advanced applications, and troubleshooting strategies that empower researchers to maximize the value of APExBIO’s Vincristine sulfate in both cellular and animal models.

552 records 15/37 page Previous Next First page 上5页 1112131415 下5页 Last page